Sphingotec sphingotec.com


Public lists: Digital Health (5963)

Sphingotec is developing and marketing biomarkers penKid and bio-ADM for prediction, diagnosis and therapy monitoring of AKI, congestive heart failure, and septic shock.

Sphingotec is developing and marketing biomarkers penKid and bio-ADM for prediction, diagnosis and therapy monitoring of AKI, congestive heart failure, and septic shock.

Company (Alive / Active)

Phone: +49 03302205650

Fax:

Neuendorfstrasse 15A

Berlin, 16761
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sphingotec $28.8M Oct 8, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sphingotec Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)